Inspira Technologies VORTX™ Tech Hits 99%+ Gas Exchange Efficiency
Ticker: IINNW · Form: 6-K · Filed: Apr 23, 2025 · CIK: 1837493
Sentiment: bullish
Topics: medical-device, technology-milestone, animal-testing
TL;DR
Inspira's VORTX™ tech shows >99% gas exchange efficiency in animal tests. Big step forward.
AI Summary
On April 23, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced successful in-vivo animal testing for its VORTX™ technology, achieving over 99% gas exchange efficiency. This milestone is detailed in a press release furnished as Exhibit 99.1 with their Form 6-K filing.
Why It Matters
This high efficiency in animal testing is a critical step towards potential human clinical trials, signaling significant progress for Inspira's respiratory support technology.
Risk Assessment
Risk Level: medium — While positive, the results are from animal testing and require further clinical trials and regulatory approval for human application.
Key Numbers
- 99% — Gas Exchange Efficiency (Achieved in VORTX™ technology in-vivo animal testing)
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- VORTX™ (technology) — Respiratory support technology
- April 23, 2025 (date) — Date of press release
FAQ
What specific animal model was used for the VORTX™ technology testing?
The filing does not specify the animal model used for the VORTX™ technology testing.
When does Inspira Technologies plan to initiate human clinical trials?
The filing does not provide a timeline for the initiation of human clinical trials.
What is the primary indication for the VORTX™ technology?
The filing implies the VORTX™ technology is for respiratory support, given its gas exchange efficiency.
Is the press release detailing these results included as an exhibit?
Yes, the press release titled 'Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing' is furnished as Exhibit 99.1.
What is the filing number for this report?
The filing number (Accession Number) for this report is 0001213900-25-034345.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 23, 2025 regarding Inspira Technologies OXY B.H.N. Ltd (IINNW).